Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Sep;75(9):1628-1637.
doi: 10.1002/art.42486. Epub 2023 Jul 4.

Reduction of Neutrophil Activation by Phosphodiesterase 4 Blockade in Behçet's Disease

Alexandre Le Joncour  1 , Paul Régnier  2 , Anna Maciejewski-Duval  2 , Erwan Charles  2 , Stéphane Barete  3 , Pierre Fouret  4 , Michelle Rosenzwajg  2 , David Klatzmann  2 , Patrice Cacoub  1 , David Saadoun  1
Affiliations

Reduction of Neutrophil Activation by Phosphodiesterase 4 Blockade in Behçet's Disease

Alexandre Le Joncour et al. Arthritis Rheumatol. 2023 Sep.

Abstract

Objective: Behçet's disease (BD) is a systemic vasculitis with inflammatory lesions mediated by cytotoxic T cells and neutrophils. Apremilast, an orally available small-molecule drug that selectively inhibits phosphodiesterase 4 (PDE4), has been recently approved for the treatment of BD. We aimed to investigate the effect of PDE4 inhibition on neutrophil activation in BD.

Methods: We studied surface markers and reactive oxygen species (ROS) production by flow cytometry, and neutrophil extracellular traps (NETs) production and molecular signature of neutrophils by transcriptome analysis before and after PDE4 inhibition.

Results: Activation surface markers (CD64, CD66b, CD11b, and CD11c), ROS production, and NETosis were up-regulated in BD patient neutrophils compared to healthy donor neutrophils. Transcriptome analysis revealed 1,021 significantly dysregulated neutrophil genes between BD patients and healthy donors. Among dysregulated genes, we found a substantial enrichment for pathways linked to innate immunity, intracellular signaling, and chemotaxis in BD. Skin lesions of BD patients showed increased infiltration of neutrophils that colocalized with PDE4. Inhibition of PDE4 by apremilast strongly inhibited neutrophil surface activation markers as well as ROS production, NETosis, and genes and pathways related to innate immunity, intracellular signaling, and chemotaxis.

Conclusion: We highlight key biologic effects of apremilast on neutrophils in BD.

PubMed Disclaimer

References

REFERENCES

    1. Saadoun D, Wechsler B. Behçet's disease [review]. Orphanet J Rare Dis 2012;7:20.
    1. Suzuki Y, Hoshi K, Matsuda T, et al. Increased peripheral blood γδ+ T cells and natural killer cells in Behçet's disease. J Rheumatol 1992;19:588-92.
    1. Yasuoka H, Yamaguchi Y, Mizuki N, et al. Preferential activation of circulating CD8+ and γδ T cells in patients with active Behçet's disease and HLA-B51. Clin Exp Rheumatol 2008;26:S59-63.
    1. Ahn JK, Chung H, Lee D, et al. CD8brightCD56+ T cells are cytotoxic effectors in patients with active Behçet's uveitis. J Immunol 2005;175:6133-42.
    1. Yamasaki O, Morizane S, Aochi S, et al. Granulysin-producing cytotoxic T cells in the mucocutaneous lesions of Behçet disease: a distinct inflammatory response from erythema nodosum. Clin Exp Dermatol 2011;36:903-7.

Publication types

MeSH terms

Substances